[HTML][HTML] Human papillomavirus vaccines effectiveness to prevent genital warts: a population-based study using health system integrated databases, 2009–2017
C Muñoz-Quiles, M López-Lacort, J Díez-Domingo… - Vaccine, 2022 - Elsevier
Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts (GW)
in women aged 14–23 years and to estimate the incidence of GW in the whole population …
in women aged 14–23 years and to estimate the incidence of GW in the whole population …
Dose-related differences in effectiveness of human papillomavirus vaccination against genital warts: a nationwide study of 550 000 young girls
M Blomberg, C Dehlendorff, C Sand… - Clinical Infectious …, 2015 - academic.oup.com
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …
Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
E Navarro-Illana, M López-Lacort, P Navarro-Illana… - Vaccine, 2017 - Elsevier
Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …
young women. Design Population-based study using health databases. Setting Valencian …
Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study
C Fernandes, J Alves, A Rodrigues, J Azevedo - Vaccine, 2022 - Elsevier
Background The quadrivalent human papillomavirus (HPV) vaccine was introduced in the
Portuguese National Immunization Program in October 2008, targeting 13-year-old girls …
Portuguese National Immunization Program in October 2008, targeting 13-year-old girls …
One-dose human papillomavirus vaccination and the risk of genital warts: a Danish nationwide population-based study
L Baandrup, C Dehlendorff… - Clinical Infectious …, 2021 - academic.oup.com
Background Increasing evidence suggests that 1-dose human papillomavirus (HPV)
vaccination may protect significantly against HPV-related disease. We provide nationwide …
vaccination may protect significantly against HPV-related disease. We provide nationwide …
Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine
SM Garland, M Steben, HL Sings… - The Journal of …, 2009 - academic.oup.com
Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …
Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark
M Blomberg, C Dehlendorff, C Munk… - Clinical infectious …, 2013 - academic.oup.com
Background. A reduction in the incidence of genital warts (GWs) is one of the first markers of
the effectiveness of vaccination against human papillomavirus (HPV) at the population level …
the effectiveness of vaccination against human papillomavirus (HPV) at the population level …
Human papillomavirus vaccine effectiveness against incident genital warts among female health-plan enrollees, United States
S Hariri, MS Schuler, AL Naleway… - American Journal of …, 2018 - academic.oup.com
We examined the effectiveness of human papillomavirus vaccination by dose number and
spacing against incident genital warts in a cohort of 64,517 female health-plan enrollees in …
spacing against incident genital warts in a cohort of 64,517 female health-plan enrollees in …
Impact of number of human papillomavirus vaccine doses on genital warts diagnoses among a national cohort of US adolescents
RB Perkins, M Lin, SF Wallington… - Sexually transmitted …, 2017 - journals.lww.com
Background The impact of fewer than 3 doses of human papillomavirus (HPV) vaccine on
genital warts is uncertain. Methods Using the Truven Health Analytics Marketscan …
genital warts is uncertain. Methods Using the Truven Health Analytics Marketscan …
Prevalence of genital warts among sexually transmitted disease clinic patients—Sexually Transmitted Disease Surveillance Network, United States, January 2010 to …
E Llata, M Stenger, K Bernstein, S Guerry… - Sexually transmitted …, 2014 - journals.lww.com
Background A quadrivalent vaccine that prevents genital warts (GWs) has been
recommended by the Advisory Committee on Immunization Practices for women since 2007 …
recommended by the Advisory Committee on Immunization Practices for women since 2007 …
相关搜索
- genital warts papillomavirus vaccine
- genital warts human papillomavirus
- genital warts hpv vaccines
- risk of genital warts
- genital warts in women
- genital warts differences in effectiveness
- genital warts vaccination program
- genital warts national cohort
- genital warts girls in denmark
- natural history of genital warts
- prevalence of genital warts
- genital warts placebo arm
- genital warts impact of number
- genital warts randomized phase
- health plan vaccine effectiveness
- impact of number human papillomavirus vaccine